Aflatoxin exposure produces serum alphafetoprotein elevations and marked oval cell proliferation in young male Pekin ducklings

Pathology

Volumn 30, Issue 1, 1998, Pages 34-39

  Sell, Stewart ^a,c   Xu, Kai Li ^a   Huff, William E ^b   Kabena, Leon F ^b   Harvery, Roger B ^b   Dunsford, Harold A ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b U States Dept Agric Mycotoxin R   (United States)

^c ALBANY MEDICAL COLLEGE   (United States)

Author keywords

Aflatoxin; Ducks; Hepatitis virus; Hepatocarcinogenesis; Hepatocellular carcinoma; Liver; Oval cells

Indexed keywords

AFLATOXIN; ALPHA FETOPROTEIN; MARKER;

ANIMAL EXPERIMENT; ARTICLE; CANCER RISK; CELL PROLIFERATION; CONTROLLED STUDY; DIET; DOSE LIVER FUNCTION RELATION; DOSE TIME EFFECT RELATION; DUCK; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; LIVER HILUS; LONG TERM EXPOSURE; MALE; NONHUMAN; PROTEIN BLOOD LEVEL;

EID: 0031920080     PISSN: 00313025     EISSN: None     Source Type: Journal    
DOI: 10.1080/00313029800169645     Document Type: Article

References (53)

1. Stuver SO, Trichopoulos D. Liver Cancer. Cancer Survey 1994; 19/20: 99-124.
2. Sun T-T, Chu Y-Y. Carcinogenesis and prevention strategy of liver cancer in areas of prevalence. J Cell Physiol 1984; Suppl. 3: 39-44.
3. Sun T, Wu S, Wu Y, Chu Y. Measurement of individual aflatoxin exposure among people having different risk for primary hepatocellular carcinoma. In: Hayashi Y, editor. Diet, Nutrition and Cancer. Utrecht: Japanese Society Press, 1986; 225-35.
4. International Agency for Research on Cancer. Overall Evaluations of Carcinogenicity: An updating of IARC Monographs 1-42. International Agency for Research on Cancer Monographs on the Evaluation of Carcinogenic Risks to Humans, 1987 Supplement 7: 96-99, 272-309.
5. Summers J, Smolec JM, Snyder R. A virus similar to hepatitis B virus associated with hepatitis and hepatoma in woodchucks. Proc Natl Acad Sci USA 1987; 75: 4533-7.
6. Omata M, Uchiumi K, Ito Y, Yokosuka O, Mori J, Terao K, et al. Duck hepatitis B virus and liver disease. Gastroenterology 1983; 85: 260-7.
7. Wang N-J. Experimental induction of liver carcinoma by mildewed maize in Qidong Hemp Ducks. Tumor Biol 1983; Suppl. 10: 180-2 (in Chinese).
8. Uchida T, Suzuki K, Esumi M, Arii M, Shikata T. Influence of aflatoxin B1 intoxication on duck livers with duck hepatitis B virus infection. Cancer Res 1988; 48: 1559-65.
9. Cova L, Wild CP, Mehrotra R, Turosov V, Shirai T, Lambert V, et al. Contribution of aflatoxin B1 and hepatitis B virus infection in the induction of liver tumors in ducks. Cancer Res 1990; 50: 2156-63.
10. Sell S, Leffert HL. An evaluation of cellular lineages in the pathogenesis of hepatocellular carcinoma. Hepatology 1982; 2: 77-86.
11. Sell S, Dunsford H. Evidence for the stem cell origin of hepatocellular carcinoma and cholangiocarcinoma. Am J Pathol 1989; 134: 1347-63.
12. Becker FF, Sell S. Early elevation of alpha-fetoprotein in N-2-fluorenylacetaminde hepatocarcinogenesis. Cancer Res 1974; 34: 2489-94.
13. Sell S, Becker FF, Leffert HL, Watabe H. Expression of an oncodevelopmental gene product (alpha-fetoprotein) during fetal development and oncogenesis. Cancer Res 1976; 36: 4239-49.
14. Gitlin D, Kitzes J. Synthesis of serum albuminembryo-specific alpha globulin and conalbumin by the chick yolk sac. Biochim Biophys Acta 1967; 147: 334-40.
15. Martin B, Vranckx P, Denoulet P, Nunez EA. Alphafetoprotein expression in intra- and extraembryonic fluid of developing chick embryo. Devel Biol 1985; 3: 352-8.
16. Sell S, Jalowayski I, Bellone C, Wepsic HT. Isolation and characterization of rat alpha-fetoprotein. Cancer Res 1972; 32: 1184-9.
17. Nishi S. Chemical and immunological properties of alpha-fetoprotein. Taisha 1975; 12: 3-8 (in Japanese).
18. Watabe H. Purification and chemical characterization of alphafetoprotein from rat and mouse. Int J Cancer 1974; 13: 377-88.
19. Ido H, Eiji K, Matsuno M. Purification and physiocochemical and immunological analysis of chicken alpha-fetoprotein. Japan J Med Sci Biol 1982; 35: 87-96.
20. Sell S. Radioimmunoassay of rat alpha-fetoprotein. Cancer Res 1973; 33: 1010-5.
21. Cullen JM, Marion PL, Sherman GJ, Hong X, Newbold JE. Hepatic neoplasms in aflatoxin B1-treated, congenital duck hepatitis B virus-infected, and virus free Pekin ducks. Cancer Res 1990; 50: 4072-80.
22. Cova L, Duflot A, Prave M, Trepo C. Duck hepatitis B virus infection, aflatoxin B1 and liver cancer in ducks. Arch Virol 1993; Suppl. 8: 81-7.
23. Cova L, Mehrotra R, Wild CP, Chutimataewin S, Cao SF, Duflot A, et al. Duck hepatitis B virus infection, aflatoxin B1 and liver cancer in domestic Chinese ducks. Br J Cancer 1994; 69: 104-9.
24. Yokosuka O, Omata M, Zhou Y-Z, Okuda K. Duck hepatitis B virus DNA in liver and serum of Chinese ducks: integration of viral DNA in a hepatocellular carcinoma. Proc Natl Acad Sci USA 1985; 82: 5180-4.
25. Summers J, Smolec JM, Snyder R. A virus similar to human hepatitis B virus associated with hepatitis and hepatoma in woodchucks. Proc Natl Acad Sci USA 1978; 75: 4533-7.
26. Summers J. Three recently described animal virus models for human hepatitis B virus. Hepatology 1981; 1: 179-83.
27. Galibert F, Ghen TN, Mandart E. Nucleotide sequence of a cloned woodchuck hepatitis virus genome: comparison with the hepatitis B virus sequence. J Virol 1982; 41: 51-6.
28. Popper HL, Roth L, Purcell RH, Tennant BC, Gerin JL. Hepatocarcinogenicity of the wood chuck hepatitis virus. Proc Natl Acad Sci USA 1987; 84: 866-70.
29. Roth L, King JM, Hornbuckle WE, Harvery HJ, Tennant BC. Chronic hepatitis and hepatocellular carcinoma associated with persistent woodchuck hepatitis virus infection. Vet Pathol 1985; 22: 338-43.
30. Fu X-X, Su CY, Lee Y, Hinz R, Biempica L, Snyder R, Rogler CE. Insulin-like growth factor II expression and oval cell proliferation associated with hepatocellular carcinogenesis in woodchuck hepatitis virus carriers. J Virol 1988; 62: 3422-30.
31. Tabor E. Strongly supported features of the association between hepatitis B virus and hepatocellular carcinoma. In: Tabor E, Bisulgi AM, Purcell RH editors. Etiology, Pathology, and Treatment of Hepatocellular Carcinoma in North America. The Woodlands, Tx: Portofilio, 1991; 107-17.
32. Sherlock S. Viruses and hepatocellular carcinoma. Gut 1994; 35: 828-32.
33. Hino O, Kajino K. Hepatitis virus-related hepatocarcinogenesis. Intervirology 1994; 37: 133-5.
34. Liang TJ, Jeffers LJ, Reddy KR, De Medina M, Parker IT, Cheinquer H, et al. Viral pathogenesis of hepatocellular carcinoma in the United States. Hepatology 1993; 18: 1326-33.
35. Szmuness W. Hepatocellular carcinoma and the hepatitis B virus: evidence for a casual association. Prog Med Virol 1978; 24: 40-69.
36. Beasley RP. Hepatitis B virus as the etiologic agent in hepatocellular carcinoma: epidemiologic considerations. Hepatology 1982; 2: 21S-26S.
37. Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22, 707 men in Taiwan. Lancet 1981; 2: 1129-33.
38. Mondelli M, Naumo N, Eddelston ALWF. The immunopathogenesis of liver cell damage in chronic hepatitis B virus infection Masson In: Chisari FV, editor. Advances in Hepatitis Research. New York 1984; 144-63.
39. Kew MC, Popper H. Relationship between hepatocellular carcinoma and cirrhosis. Sem Liver Dis 1984; 2: 136-46.
40. Callea F, Brisgotti M, Fabbretti G, Sciot R, Van Eyken P, Pavret M. Cirrhosis of the liver: a regenerative process. Dig Dis Sci 1991; 36: 1287-93.
41. Cohen S, Ellwein LB. Genetic errors, cell proliferation, and carcinogenesis. Cancer Res 1991; 51: 6493-505.
42. DiBisceglie AM, Rustgi VK, Hoofnagle JH, Dusheiko GM, Lotze MT. Hepatocellular carcinoma. Ann Int Med 1988; 108: 390-401.
43. Rustgi VK. Epidemiology of hepatocellular carcinoma. Gastroenterol Clin North Am 1987; 16: 545-51.
44. Simonetti RG, Camma C, Fiorello F, Politi F, d'Amico F, Pahliari L. patocellular carcinoma. A world wide problem and the major risk factors. Dig Dis Sci 1991; 36: 962-72.
45. Ozturk M, Bressac B, Puisieux A, Kew M, Volkmann M, Bozcall S, et al. p53 mutation in hepatocellular carcinoma after Aflatoxin B1 exposure. Lancet 1991; 338: 1356-9.
46. Munoz N, Bosch F. Epidemiology of hepatocellular carcinoma In: Okuda K, Ishak K, editors. Neoplasms of the Liver Tokyo Springer-Verlag 1987; 13-9.
47. Bressac B, Kew M, Wands J, Ozturk M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from Southern Africa. Nature 1991; 350: 429-31.
48. Yeh FS, Yu MC, Mo CC, Luo S, Tong MJ, Henderson BE. Hepatitis B Virus, aflatoxin and hepatocellular carcinoma in Southern Guangxi, China. Cancer Res 1987; 49: 2506-9.
49. Van Rensburg SJ, Cook-Mozaffari P, Van Schalkwyk DJ. Hepatocellar carcinoma and dietary aflatoxin in Mozambique and Transkei. Br J Cancer 1985; 51: 713-26.
50. Yu SX. Epidemiology of primary liver cancer. In: Tang ZY, editor, Subclinical Hepatocellular Carcinoma, Berlin: Springer-Verlag, 1989; 189-212.
51. Delong S. Drinking water and liver cell cancer. An epidemiologic approach to the etiology of this disease in China. Chinese Med J 1979; 92: 748-56.
52. Li KC, Li H-P, Wong S-S, Chuang Y-S. Survey of aflatoxin contaminations in peanuts from various areas in Taiwan. Taichung: Taiwan Agricultural Chemical and Toxin Substances Research Institute 1977; 37.
53. Chen C-J, Wang L-Y, Lu S-N Wu M-H, You S-L, Zhang Y-J, et al. Elevated aflatoxin exposure and increased risk of hepatocellular carcinoma. Hepatology 1996; 24: 38-42.